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Cognitive disorders have become a major theme in modern neu-
roscience. Analyzing the impact of these conditions at various
levels, from personal to social and economic, it is not surpris-
ing that the amount of research on this subject has grown to
vast figures in the past years, thus making it hard to keep up
with the sum of publications and novelties in this field, especially
for the busy clinician. On the other hand, basic and transla-
tional scientists frequently find it difficult to explore the vast
and often complex clinical literature on this matter, as well
as understand the clinical features of these disorders, in order
to define the current research needs and optimal future direc-
tions in innovation. The main aim of the Frontiers Research
Topic “Cognitive impairment and dementia—an update” is to
deliver an updated synthesis regarding the current knowledge
and literature in this field, which will hopefully benefit clin-
icians and scientists from various fields. In this regard, open
access publication brings clear advantages. We have been very for-
tunate, as outstanding contributions from several authors and
working groups have been submitted, covering a wide range
of subjects.
Galimberti and Scarpini (2012) have approached the ever
more complex subject of frontotemporal dementia genet-
ics. This mini-review deals with the major issues regard-
ing this topic, including genes involved, phenotypic aspects,
and even the fresh scientific breakthrough in this field—the
association between FTD and the pathologic hexanucleotide
repeat expansion in the C9ORF72 gene. This scientific novelty
brought a long looked-for molecular explanation for a signif-
icant number of cases seen in clinic, especially those associ-
ated with amyotrophic lateral sclerosis and a positive family
history.
Alves et al. (2012) have produced a comprehensive review
concerning the most important aspects of Alzheimer’s disease
(AD), including clinical features, genetics, pathophysiology, clini-
cal genetic testing, diagnostic strategies, and management. This
article is very well complemented by the manuscript from de
Mendonça (2012), who provides important reflections con-
cerning the recent changing paradigms of clinical and scien-
tific thinking in AD. Contributing also to the topic of AD,
Sá et al. (2012) share their research on the neuropsychologi-
cal aspects of early and late onset AD. This is a large series
from one single group detaining extensive experience in this
field.
Mild cognitive impairment and dementia have been recog-
nized as important features of Parkinson’s disease (PD) in the
last few years, despite the traditional emphasis on motor symp-
toms of the disease (Massano, 2011; Massano and Bhatia, 2012).
In this regard, Meireles and Massano (2012) have written a broad
review concerning the issue of cognitive decline in PD, cov-
ering the stages of mild cognitive impairment and dementia.
Phenotypic aspects have been approached, as well as diagnostic
issues, genetic factors, and practical management strategies. The
paper by Almeida (2012) delves further on the role of glucocere-
brosidase in PD and other neurodegenerative conditions, a topic
receiving currently much attention from basic and translational
researchers, as well as clinicians. Other genes related to lysosomal
functioning have also been dealt with in the text. The manuscript
by Massano and Garrett (2012) complements the theme of cog-
nitive impairment in PD by in-depth reviewing the literature
regarding the cognitive effects of deep brain stimulation in these
patients, and the importance of accurate preoperative cognitive
assessment, as well as some ethical issues in this setting.
Neuropathology has traditionally been an important diagnos-
tic instrument in cognitive disorders, and pathological findings
have provided the basis for important genetic and pathophysio-
logical lines of research along the years. However, this is a complex
subject, especially in the context of neurodegenerative disorders,
and non-pathologists find it difficult to keep up with the termi-
nology. The article by Taipa et al. (2012) will be a precious aid to
all of those interested in learning more about this subject or sim-
ply optimize their current level of knowledge, as it summarizes
important neuropathological findings in the most common neu-
rodegenerative dementias, establishing also a relationship with
relevant clinical features.
Behavioral and psychological symptoms of dementia are a
major source of disability and decrement in quality of life, as well
as caregiver burden. Moreover, they are commonly difficult to
tackle in practice, even for experienced clinicians. Cerejeira et al.
(2012) have produced a very useful and comprehensive text on
this subject, ranging from diagnosis to management, which will
greatly benefit the readership.
Cognitive dysfunction in multiple sclerosis (MS) is a partic-
ularly sensitive issue, as this disease afflicts preferentially young
adults, being one of the most important causes of neurologically
induced disability in this age range. A few important ideas can be
extracted from the paper by Guimarães and Sá (2012), such as the
fact that, beyond every other symptoms of the disease, cognitive
dysfunction in MS is a matter to keep in mind. Patients deserve
proper assessment and management, as groundbreaking disease
modifying therapies became available along the years.
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Elderly people are naturally at higher risk of sustaining con-
fusional states, especially those who suffer from previous brain
disease leading to cognitive impairment. Unfortunately, delirium
is still too often overlooked by clinicians, which brings onerous
consequences to patients, since management opportunities are
lost and outcome will be less favorable, as Martins and Fernandes
point out in their manuscript (Martins and Fernandes, 2012).
This is a very common disorder, which only stresses the impor-
tance of professional education and awareness on these matters.
Broadly speaking, this is obviously another important aim of this
Frontiers Research Topic.
Finally, an inclusive acknowledgment is due to the authors
who, with their hard work, have contributed to this Frontiers
Research Topic. In addition, reviewers should also here be
appraised, as themanuscripts have clearly been improved after the
successive comments posted on the review forums. Their honest
efforts and purely altruistic commitment with this challenge have
been truly admirable.
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